Compound ID | 282
Class: Sulfa drug / Sulphonamide
| Spectrum of activity: | Gram-negative |
| Details of activity: | Dehydroquinate synthase inhibitors |
| Propensity to select resistant mutants: | Yes: resistance studies failed to identify mutants not susceptible to A358 |
| Institute where first reported: | Arrow Therapeutics |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9894770 |
| Citation: |